NOTCH1 and SF3B1 mutations can be added to the hierarchical prognostic classification in chronic lymphocytic leukemia von Mansouri, L, Cahill, N, Gunnarsson, R, Smedby, K E, Tjönnfjord, E, Hjalgrim, H, Juliusson, G, Geisler, C, Rosenquist, R

Volltext

Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination von Schultz, Nina H, Sørvoll, Ingvild H, Michelsen, Annika E, Munthe, Ludvig A, Lund-Johansen, Fridtjof, Ahlen, Maria T, Wiedmann, Markus, Aamodt, Anne-Hege, Skattør, Thor H, Tjønnfjord, Geir E, Holme, Pål A

Volltext

Cold agglutinin disease revisited: a multinational, observational study of 232 patients von Berentsen, Sigbjørn, Barcellini, Wilma, D'Sa, Shirley, Randen, Ulla, Tvedt, Tor Henrik Anderson, Fattizzo, Bruno, Haukås, Einar, Kell, Megan, Brudevold, Robert, Dahm, Anders E.A., Dalgaard, Jakob, Frøen, Hege, Hallstensen, Randi Fykse, Jæger, Pernille H., Hjorth-Hansen, Henrik, Małecka, Agnieszka, Oksman, Markku, Rolke, Jürgen, Sekhar, Mallika, Sørbø, Jon Hjalmar, Tjønnfjord, Eirik, Tsykunova, Galina, Tjønnfjord, Geir E.

Volltext

Primary cold agglutinin-associated lymphoproliferative disease: a B-cell lymphoma of the bone marrow distinct from lymphoplasmacytic lymphoma von Randen, Ulla, Trøen, Gunhild, Tierens, Anne, Steen, Chloé, Warsame, Abdirashid, Beiske, Klaus, Tjønnfjord, Geir E, Berentsen, Sigbjørn, Delabie, Jan

Volltext

Diagnosis and treatment of cold agglutinin mediated autoimmune hemolytic anemia von Berentsen, Sigbjørn, Tjønnfjord, Geir E

Volltext

Bendamustine plus rituximab for chronic cold agglutinin disease: results of a Nordic prospective multicenter trial von Berentsen, Sigbjørn, Randen, Ulla, Oksman, Markku, Birgens, Henrik, Tvedt, Tor Henrik Anderson, Dalgaard, Jakob, Galteland, Eivind, Haukås, Einar, Brudevold, Robert, Sørbø, Jon Hjalmar, Næss, Inger Anne, Malecka, Agnieszka, Tjønnfjord, Geir E.

Volltext

The PI3K p110δ Isoform Inhibitor Idelalisib Preferentially Inhibits Human Regulatory T Cell Function von Chellappa, Stalin, Kushekhar, Kushi, Munthe, Ludvig A, Tjønnfjord, Geir E, Aandahl, Einar M, Okkenhaug, Klaus, Taskén, Kjetil

Volltext

Current Treatment Options in Cold Agglutinin Disease: B-Cell Directed or Complement Directed Therapy? von Berentsen, Sigbjørn, Tjønnfjord, Geir E.

Volltext

Frequent somatic mutations of KMT2D (MLL2) and CARD11 genes in primary cold agglutinin disease von Małecka, Agnieszka, Trøen, Gunhild, Tierens, Anne, Østlie, Ingunn, Małecki, Jędrzej, Randen, Ulla, Wang, Junbai, Berentsen, Sigbjørn, Tjønnfjord, Geir E., Delabie, Jan M. A.

Volltext

RUNX1::MIR99AHG Chimera in Acute Myeloid Leukemia von Andersen, Kristin, Tjønnfjord, Geir E., Ramslien, L. Frode, Panagopoulos, Ioannis

Volltext

Cold agglutinin disease: current challenges and future prospects von Berentsen, Sigbjørn, Röth, Alexander, Randen, Ulla, Jilma, Bernd, Tjønnfjord, Geir E

Volltext

Functional testing of relapsed chronic lymphocytic leukemia guides precision medicine and maps response and resistance mechanisms. An index case von Skånland, Sigrid S, Inngjerdingen, Marit, Bendiksen, Henrik, York, Jamie, Spetalen, Signe, Munthe, Ludvig A, Tjønnfjord, Geir E

Volltext

A Dominant STIM1 Mutation Causes Stormorken Syndrome von Misceo, Doriana, Holmgren, Asbjørn, Louch, William E., Holme, Pål A., Mizobuchi, Masahiro, Morales, Raul J., De Paula, André Maues, Stray-Pedersen, Asbjørg, Lyle, Robert, Dalhus, Bjørn, Christensen, Geir, Stormorken, Helge, Tjønnfjord, Geir E., Frengen, Eirik

Volltext

Continuous infusion of coagulation factor concentrates during intensive treatment von Holme, P. A., Tjønnfjord, G. E., Batorova, A.

Volltext

Joint health and treatment modalities in Nordic patients with moderate haemophilia A and B – The MoHem study von Måseide, Ragnhild J., Berntorp, Erik, Astermark, Jan, Olsson, Anna, Bruzelius, Maria, Frisk, Tony, Nummi, Vuokko, Lassila, Riitta, Tjønnfjord, Geir E., Holme, Pål A.

Volltext

Determining drug dose in the era of targeted therapies: playing it (un)safe? von Skånland, Sigrid S., Tjønnfjord, Geir E.

Volltext

Body weight, body composition and survival after 1 year: follow-up of a nutritional intervention trial in allo-HSCT recipients von Skaarud, K. J., Veierød, M. B., Lergenmuller, S., Bye, A., Iversen, P. O., Tjønnfjord, G. E.

Volltext

Rituximab as second-line treatment for adult immune thrombocytopenia (the RITP trial): a multicentre, randomised, double-blind, placebo-controlled trial von Ghanima, Waleed, Dr, Khelif, Abderrahim, Prof, Waage, Anders, Prof, Michel, Marc, Prof, Tjønnfjord, Geir E, Prof, Romdhan, Neila Ben, MD, Kahrs, Johannes, MD, Darne, Bernadette, MD, Holme, Pål Andrè, Prof

Volltext

Chronic lymphocytic leukemia cells are activated and proliferate in response to specific T helper cells von Os, Audun, Bürgler, Simone, Ribes, Anna Parente, Funderud, Ane, Wang, Dong, Thompson, Keith M, Tjønnfjord, Geir E, Bogen, Bjarne, Munthe, Ludvig A

Volltext

High prevalence of hereditary thrombotic thrombocytopenic purpura in central Norway: from clinical observation to evidence von Krogh, A. S., Quist‐Paulsen, P., Waage, A., Langseth, Ø. O., Thorstensen, K., Brudevold, R., Tjønnfjord, G. E., Largiadèr, C. R., Lämmle, B., Kremer Hovinga, J. A.

Volltext